Objective
The XANA project aims at developing a user-friendly wearable device and ICT solution for the customized treatment of stress. We will provide an innovative and non-invasive technology of stimulation of the vagus nerve and a range of integrated services such as feedback on performance, monitoring and access to professional counselling when needed.
Stress is suffered by over 26% of working population. The European Commission estimated in 2002 the cost of work-related stress at €20 billion a year just in the EU-15. Of this, direct costs are mostly paid by the public healthcare systems, and indirect costs are related to productivity loss, ultimately impacting national economies.
Current alternatives do not fully solve the challenge of stress treatment, because of their limited efficacy and presence of secondary effects (invasive electrical stimulation or pharmacological treatment). Moreover, the treatment results are very variable, time consuming (psychological techniques) and expensive. XANA main benefits are: avoidance of secondary effects, high efficacy, user-friendliness, fast and customized treatment providing actual physiological activity. XANA will contribute to the development of mobile Health in Europe. In this, the ICT characteristics of the product are key to possibly enabling burden-reduction in healthcare systems through real-time treatment optimisation and remote medical monitoring/counselling.
XANA project is led by the Spanish start-up Walden Medical®. XANA has a clear potential for becoming an international benchmark in the field of mental health. We have estimated that after 5 years from launch, we will build around 69.700 devices (sales €28M), hire 12 technical employees and manage 0.1% of the world market. We will earn around €10M profit and generate a R.O.I of 6.90. Investment in the XANA product will furthermore ease commercialization of Walden Medical® technologies for other high prevalence conditions: anxiety and migraine.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciences biological sciences neurobiology
- natural sciences computer and information sciences internet internet of things
- medical and health sciences clinical medicine psychiatry
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
- medical and health sciences basic medicine physiology homeostasis
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
33203 GIJON
Spain
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.